Browse by:
Research & Development

Voya launches finance institute to research retirement issues

Patricia Daddona |

Voya Financial Inc. on Tuesday launched the Voya Behavioral Finance Institute for Innovation, an effort to gain insight regarding Americans' retirement planning and decision-making.

UConn, Stamford firm establish cybersecurity center

Patricia Daddona |

The UConn School of Engineering is launching the Synchrony Financial's Center of Excellence in Cybersecurity with an investment of $2.2 million over five years from the company and UConn.

The Hartford, UCLA team up on small business research

Patricia Daddona |

The Hartford has partnered with UCLA Anderson Forecast in an effort to more thoroughly research a persistent decline in new business formation across states and industries.

UConn Health opens extensive new Farmington research space

Patricia Daddona |

UConn Health officially opened 32 new research laboratories and 40 offices at its Farmington campus, an initiative funded by the state's expansive for Bioscience Connecticut efforts.

Incentives granted in EU for Alexion drug

Patricia Daddona |

New Haven-based Alexion Pharmaceuticals Inc. has obtained orphan drug status in Europe for a new anti-inflammatory antibody developed to treat graft-versus host disease.

NASA funds CT firm's air-scrubber

Gregory Seay |

A North Haven clean-technology company says it won a NASA contract for its innovation of lightweight, regenerable air cleaners for scrubbing breathable toxins from spacesuits.

Cromwell's BI, Corning to co-brand stem-cell media

Gregory Seay |

Biological Industries USA, an Israeli bioscience firm with Cromwell operations, says it signed a co-branding agreement with giant Corning Inc. to market BI's proprietary medium for growing stem cells.

Walnuts may fight colon cancer

UConn researchers, in a report published in the journal Cancer Prevention Research, are saying walnuts may be an effective tool for fighting colon cancer.

Alexion reports flat 1Q profits

Keith Griffin |

New Haven biopharma Alexion said Thursday its first-quarter profits were largely flat from a year earlier, despite 17 percent revenue growth.

Copyright 2016 New England Business Media